Information presentation and decisions to enter clinical trials: a hypothetical trial of hormone replacement therapy.

[1]  W. Hong,et al.  The Biology and Prevention of Aerodigestive Tract Cancers , 2012, Advances in Experimental Medicine and Biology.

[2]  A. Tversky,et al.  Choices, Values, and Frames , 2000 .

[3]  R. Lilford,et al.  Informed consent for clinical trials: in search of the "best" method. , 1998, Social science & medicine.

[4]  N. Davidson.  Is hormone replacement therapy a risk? , 1996, Scientific American.

[5]  F. V. van Wijmen,et al.  Informed consent in clinical trials. , 1996, Health policy.

[6]  R J Lilford,et al.  Equipoise and the ethics of randomization. , 1995, Journal of the Royal Society of Medicine.

[7]  E. Topol,et al.  Are we promoting true informed consent in cardiovascular clinical trials? , 1995, The Journal of cardiovascular nursing.

[8]  H. Llewellyn-Thomas,et al.  Cancer Patients' Decision Making and Trial-entry Preferences , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  D. Cooper,et al.  Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine. , 1994, Patient education and counseling.

[10]  W S Schain,et al.  Barriers to clinical trials: Part II: Knowledge and attitudes of potential participants , 1994 .

[11]  L J Mahoney,et al.  Reasons for non‐entry in randomized clinical trials for breast cancer: A single institutional study , 1992, Journal of surgical oncology.

[12]  A. Rademaker,et al.  Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Piantadosi,et al.  Effect of patients' expectations of benefit with standard breast cancer adjuvant chemotherapy on participation in a randomized clinical trial: a clinical vignette study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Siminoff,et al.  Doctor-patient communication about breast cancer adjuvant therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  T. Marteau,et al.  Framing of information: its influence upon decisions of doctors and patients. , 1989, The British journal of social psychology.

[16]  S. Chaiken,et al.  The effect of message framing on breast self-examination attitudes, intentions, and behavior. , 1987, Journal of personality and social psychology.

[17]  R. Simes,et al.  Randomised comparison of procedures for obtaining informed consent in clinical trials of treatment for cancer. , 1986, British medical journal.

[18]  B. Lo,et al.  Do patients want to participate in medical decision making? , 1984, JAMA.

[19]  J. Bennett,et al.  Cancer patient accessions into clinical trials: a pilot investigation into some patient and physician determinants of entry. , 1982, American journal of clinical oncology.

[20]  T C Chalmers,et al.  Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.

[21]  D. DeMets,et al.  How informed is informed consent?: The BHAT experience , 1981 .

[22]  A. Baum,et al.  Assessment of Preferences for self-treatment and information in health care. , 1980, Journal of personality and social psychology.

[23]  A. Tversky,et al.  Decision, probability, and utility: Prospect theory: An analysis of decision under risk , 1979 .

[24]  Kenneth A. Wallston,et al.  Development of the Multidimensional Health Locus of Control (MHLC) Scales , 1978, Health education monographs.

[25]  R. Flesch.  A new readability yardstick. , 1948, The Journal of applied psychology.

[26]  C. Williams,et al.  Informed consent in European multicentre randomised clinical trials--are patients really informed? , 1994, European journal of cancer.

[27]  C. Rose,et al.  Information for cancer patients entering a clinical trial--an evaluation of an information strategy. , 1993, European journal of cancer.

[28]  B. Rimer.  Participant enrollment, participation, and compliance in chemoprevention trials. , 1992, Advances in experimental medicine and biology.

[29]  H. Llewellyn-Thomas,et al.  Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. , 1991, Social science & medicine.

[30]  P. Byrne.  Ethics and law in health care and research , 1990 .

[31]  Suzanne M. Miller,et al.  Styles of coping with threat: implications for health. , 1988, Journal of personality and social psychology.